
Tech Tomorrow · 2024-04-17 · 27 min
According to Alzheimer's Disease International, the number of people around the world with the condition will reach 78 million in 2030, and 139 million in 2050. As of 2024, there is no known cure for Alzheimer's, dementia, or similar degenerative brain conditions. So, how are those testing for these diseases using data and technology to help improve health outcomes? Today’s guest is Rhoda Au, Professor of Anatomy & Neurobiology, Neurology, and Epidemiology at Boston University, and Director of Neuropsychology at the Framingham Heart Study. She’s also the Director of Global Cohort Development at the Davos Alzheimer's Collaborative. We discuss Rhoda’s experience of paper-and-pen Alzheimer's testing in the early 90s, her switch to voice capture in 2005, and her thoughts about how medical data should be shared.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.